# Thermo Fisher Scientific

**Source:** https://geo.sig.ai/brands/thermo-fisher-scientific  
**Vertical:** Healthcare Tech  
**Subcategory:** Enterprise  
**Tier:** Leader  
**Website:** thermo-fisher-scientific.com  
**Last Updated:** 2026-04-14

## Summary

Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.

## Company Overview

Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.

Thermo Fisher's business spans four segments: Life Sciences Solutions (bioproduction, genetic analysis, cell biology), Analytical Instruments (mass spectrometers, chromatography, electron microscopes), Specialty Diagnostics (clinical diagnostics, immunoassays), and Laboratory Products and Biopharma Services (pharma services, lab distribution). Every major pharmaceutical company, biotech, hospital, university research lab, and government agency is a Thermo Fisher customer. The company played a critical role in COVID-19 response — manufacturing PCR tests, reagents, and vaccine production materials at unprecedented scale.

Thermo Fisher trades on NYSE (TMO) with a market cap of approximately $180B. CEO Marc Casper has executed a disciplined M&A strategy (acquiring Life Technologies, FEI, Patheon, PPD, and others) to build an unmatched life sciences platform. The company's Pharma Services segment (contract manufacturing for biologics and small molecules) is a high-growth unit benefiting from biotech outsourcing trends. AI integration in laboratory workflows and drug discovery is an emerging opportunity.

## Frequently Asked Questions

### What is Thermo Fisher's annual revenue?
Thermo Fisher Scientific reported $42.9B in revenue for FY2024, slightly down year-over-year as the COVID tailwinds (testing, vaccine production) normalized. Core organic growth in life sciences and pharma services remained positive.

### What does Thermo Fisher make?
Thermo Fisher provides instruments, reagents, consumables, and services for scientific research and healthcare. Products include mass spectrometers, PCR systems, electron microscopes, cell culture media, clinical diagnostics, and pharma contract manufacturing services.

### What is Thermo Fisher's stock ticker?
Thermo Fisher Scientific trades on NYSE under ticker TMO. It is a component of the S&P 500.

### Who uses Thermo Fisher products?
Thermo Fisher serves pharmaceutical and biotech companies, hospitals and clinical labs, university and government research institutions, environmental testing labs, and food safety testing organizations globally.

### Who are Thermo Fisher's main competitors?
Thermo Fisher's primary competitors include Danaher, Merck KGaA (MilliporeSigma), Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, and Sartorius across its various product lines.

### What is Thermo Fisher's role in pharmaceutical contract manufacturing?
Thermo Fisher's Pharma Services Group (PSG) is one of the world's largest contract development and manufacturing organizations (CDMOs), manufacturing clinical trial materials and commercial drug products for hundreds of pharma and biotech companies. PSG produces everything from small molecule APIs to biological drug substances (including mRNA therapeutics and cell and gene therapies), providing end-to-end manufacturing from molecule to finished dose.

### How has Thermo Fisher positioned itself in the cell and gene therapy market?
Thermo Fisher has invested over $1 billion building out cell and gene therapy manufacturing capacity, acquiring Brammer Bio (viral vector manufacturing, $1.7B, 2019) and expanding facilities in the US, Europe, and Asia. The company provides instruments, reagents, and contract manufacturing for CAR-T cell therapies, gene editing programs, and viral vector-based vaccines — positioning Thermo Fisher as a critical supplier to the rapidly growing advanced therapy market.

### What is Thermo Fisher's AI and informatics strategy?
Thermo Fisher's informatics portfolio includes its Thermo Scientific Connect platform for lab data management and its partnership with software companies for laboratory information management systems (LIMS). The company uses AI internally to optimize clinical trial supply chain logistics and manufacturing quality control. It has also partnered with AI drug discovery companies who use Thermo Fisher instruments and services to generate biological data for their AI models.

## Tags

b2b, healthtech, manufacturing, saas, public

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*